Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01721603
Title A Phase 2 Prospective Trial of Dabrafenib With Stereotactic Radiosurgery in BRAFV600E Melanoma Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, San Francisco




Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of San Francisco, California San Francisco California 94115 United States Details
*Shaded cells indicate that there was no data available from for the field